NDC 51672-4046-01 - Enalapril Maleate and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4046
- Requested NDC
- 51672-4046-01
- Package NDCs from labels
- 51672-4046-1, 51672-4046-3, 51672-4046-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd.
- Effective date
- 2026-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Enalapril Maleate and Hydrochlorothiazide Tablets, USP | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate and Hydrochlorothiazide Tablets, USP | NuCare Pharmaceuticals,Inc. | 2021-02-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate and Hydrochlorothiazide - Rebel Distributors Corp | Rebel Distributors Corp | 2010-12-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4046-1 | Enalapril Maleate and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 12 | |
| 51672-4046-3 | Enalapril Maleate and Hydrochlorothiazide | 1000 in 1 BOTTLE | TABLET | 1000 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4046 | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 12 | Current NDC, Legacy NDC, 2 package rows | 20240509_7cb92cf2-46f2-4379-937c-168d230e43a4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4046-1 | EA - Each | 51672-4046 | 0843b439-9694-412b-a9b3-6db98999e827 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 53ce6e4f-db3a-4789-8bef-1e459fa78b79 | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| TINTED SUNSCREEN FOUNDATION | TINTED SUNSCREEN FOUNDATION | Guanghzou AiXin Biotech Co Ltd | 396393c4-b50c-3877-e063-6294a90a0e9b | 2026-03-17 | Warnings | 059QF0KO0R |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 4d3a0a92-b0de-a1ea-e063-6294a90a8508 | 2026-03-17 | Warnings | 1K09F3G675 |
| Enalapril maleate | ENALAPRIL MALEATE | A-S Medication Solutions | 9f913e79-fe6d-4ff2-9f8e-eef9df689fa8 | 2026-03-17 | Warnings, Adverse reactions | 9O25354EPJ |
| equate omeprazole and sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | WALMART INC. | c24c3326-99da-4c7d-aecc-7b4a8ac3f04e | 2026-03-15 | Warnings | 8MDF5V39QO |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 905568ae-ce27-4978-90c7-b5c93279ecd1 | 2026-03-12 | Warnings, Adverse reactions | 0J48LPH2TH |
| Enalapril Maleate | ENALAPRIL MALEATE | NuCare Pharmaceuticals, Inc. | 315baaa6-512c-f27b-e063-6294a90a2c91 | 2026-03-12 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| Enalapril maleate | ENALAPRIL MALEATE | Legacy Pharmaceutical Packaging, LLC | ed7536f1-9a7d-4519-e053-2a95a90a4a65 | 2026-03-11 | Warnings, Adverse reactions | 9O25354EPJ |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Mylan Pharmaceuticals Inc. | 0c8c973f-13a2-4883-8316-4006398e2931 | 2026-03-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| Benicar HCT | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | Cosette Pharmaceuticals, Inc. | a90915ca-f9d3-4fff-8370-d5dc4cdfc521 | 2026-03-10 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL AND HYDROCHLOROTHIAZIDE | LISINOPRIL AND HYDROCHLOROTHIAZIDE | St Marys Medical Park Pharmacy | e7b68ea6-4fc8-441a-9640-1ccd3a482d8e | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Hospira, Inc. | 084f5572-8c1f-4802-b179-ca0cc838fc68 | 2026-03-09 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | 0c24b592-4bc8-456f-acac-9c9525844a06 | 2026-03-09 | Warnings, Adverse reactions | 8MDF5V39QO |
| 2-Pack Facial Serum | 2-PACK FACIAL SERUM | Guangzhou Ariel Biotech Co., Ltd. | 27c7f645-cfb3-6db1-e063-6394a90a42ff | 2026-03-06 | Warnings | 059QF0KO0R |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | American Health Packaging | 2ec371a5-18ba-4ce2-9725-7f99bb73454a | 2026-03-05 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Legacy Pharmaceutical Packaging, LLC | 1d6ea4b4-1e3c-4f3f-989c-1a3a3c0da6bd | 2026-03-05 | Warnings | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Legacy Pharmaceutical Packaging, LLC | 6d729ec5-7311-4534-9999-9d6fa4f3ba2f | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Direct Rx | d838e918-2463-79f6-e053-2a95a90a948d | 2026-03-05 | Warnings, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 9271a2d7-be94-4e38-9f71-41e8d55e10bc | 2026-03-03 | Warnings, Adverse reactions | 0J48LPH2TH |
| Calamine | CALAMINE, PRAMOXINE HCL | Amazon.com Services LLC | aceb0b10-8c90-4a06-8c47-cd1a2b4676a3 | 2026-03-03 | Warnings, Adverse reactions | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.